Vanda Pharmaceuticals Inc (VNDA)
4.48
-0.08
(-1.75%)
USD |
NASDAQ |
Apr 25, 16:00
4.49
+0.01
(+0.22%)
After-Hours: 20:00
Vanda Pharmaceuticals Profit Margin (Quarterly): -5.30% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.30% |
| September 30, 2023 | 0.35% |
| June 30, 2023 | 3.30% |
| March 31, 2023 | 5.20% |
| December 31, 2022 | 10.64% |
| September 30, 2022 | 5.01% |
| June 30, 2022 | 4.00% |
| March 31, 2022 | -10.68% |
| December 31, 2021 | 10.41% |
| September 30, 2021 | 11.09% |
| June 30, 2021 | 14.22% |
| March 31, 2021 | 13.80% |
| December 31, 2020 | 12.11% |
| September 30, 2020 | 9.86% |
| June 30, 2020 | 14.01% |
| March 31, 2020 | 0.84% |
| December 31, 2019 | 6.92% |
| September 30, 2019 | |
| June 30, 2019 | 19.52% |
| March 31, 2019 | -1.28% |
| December 31, 2018 | 19.53% |
| September 30, 2018 | 14.59% |
| June 30, 2018 | 9.74% |
| March 31, 2018 | 7.03% |
| December 31, 2017 | -4.15% |
| Date | Value |
|---|---|
| September 30, 2017 | -11.01% |
| June 30, 2017 | -3.65% |
| March 31, 2017 | -20.43% |
| December 31, 2016 | -1.58% |
| September 30, 2016 | -1.12% |
| June 30, 2016 | -12.82% |
| March 31, 2016 | -37.15% |
| December 31, 2015 | -46.46% |
| September 30, 2015 | -33.38% |
| June 30, 2015 | -19.53% |
| March 31, 2015 | -46.14% |
| December 31, 2014 | |
| September 30, 2014 | -9.65% |
| June 30, 2014 | -198.6% |
| March 31, 2014 | -290.2% |
| December 31, 2013 | -88.20% |
| September 30, 2013 | -62.07% |
| June 30, 2013 | -40.67% |
| March 31, 2013 | -56.01% |
| December 31, 2012 | -92.45% |
| September 30, 2012 | -64.26% |
| June 30, 2012 | -95.57% |
| March 31, 2012 | -97.80% |
| December 31, 2011 | -65.99% |
| September 30, 2011 | -38.57% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-10.68%
Minimum
Mar 2022
19.52%
Maximum
Jun 2019
6.96%
Average
8.39%
Median
Profit Margin (Quarterly) Benchmarks
| ADMA Biologics Inc | -23.88% |
| INVO Bioscience Inc | -144.4% |
| Johnson & Johnson | 25.04% |
| Nektar Therapeutics | -176.2% |
| Invivyd Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.47% |
| Return on Assets | 0.39% |
| Return on Invested Capital | 0.47% |
| Gross Profit Margin (Quarterly) | 92.36% |
| Operating Margin (Quarterly) | -15.67% |
| Return on Net Operating Assets | 3.10% |